Volta Medical has introduced the first U.S.-developed electrophysiology software created through its Joint Development Agreement with GE HealthCare, marking a major advancement in AI-enabled care for underserved complex atrial fibrillation (AF) patients.
The launch brings the new AF-Xplorer II AI system together with GE HealthCare’s CardioLab™ AltiX AI.i EP recording platform. This integration combines enhanced signal clarity with AI-driven interpretation to support electrophysiologists in addressing the challenges of AF ablation through a more connected and intuitive workflow.
The initial clinical experience with the combined technologies will be showcased by Dr. Julien Seitz of Hospital Saint Joseph, Marseille, during the Rhythm Interventions Online (RIO) Symposium on November 23, 2025, at 9:05 a.m. EST.
This collaboration represents a coordinated effort to advance electrophysiology by pairing GE HealthCare’s well-established EP recording capabilities with Volta Medical’s AI-guided insights. Together, the companies aim to provide practical, interoperable tools that enhance procedural decision-making and improve outcomes in complex AF care.
